Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
The path to a better biomarker: application of a risk management framework for the implementation of PD-L1 and TILs as immuno-oncology biomarkers in breast cancer clinical trials and daily practice.
Journal: The Journal of pathology
Published: February 06, 2020
The Society for Immunotherapy of Cancer statement on best practices for multiplex immunohistochemistry (IHC) and immunofluorescence (IF) staining and validation.
Journal: Journal for immunotherapy of cancer
Published: January 09, 2020
Clinical Utility of the Combined Positive Score for Programmed Death Ligand-1 Expression and the Approval of Pembrolizumab for Treatment of Gastric Cancer.
Journal: Archives of pathology & laboratory medicine
Published: July 21, 2018
Analytical validation of quantitative immunohistochemical assays of tumor infiltrating lymphocyte biomarkers.
Journal: Biotechnic & histochemistry : official publication of the Biological Stain Commission
Published: June 05, 2018
Use of the 22C3 anti-programmed death-ligand 1 antibody to determine programmed death-ligand 1 expression in cytology samples obtained from non-small cell lung cancer patients.
Journal: Cancer cytopathology
Published: November 28, 2017
Correction: Use of the 22C3 anti-PD-L1 antibody to determine PD-L1 expression in multiple automated immunohistochemistry platforms.
Journal: PloS one
Published: October 14, 2017
Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non-Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors.
Journal: Advances in anatomic pathology
Published: August 05, 2017
Assessing Tumor-infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method From the International Immunooncology Biomarkers Working Group: Part 1: Assessing the Host Immune Response, TILs in Invasive Breast Carcinoma and Ductal Carcinoma In Situ, Metastatic Tumor Deposits and Areas for Further Research.
Journal: Advances in anatomic pathology
Published: August 05, 2017
Safety and activity of pembrolizumab in patients with locally advanced or metastatic urothelial cancer (KEYNOTE-012): a non-randomised, open-label, phase 1b study.
Journal: The Lancet. Oncology
Published: August 20, 2016
PD-L2 Expression in Human Tumors: Relevance to Anti-PD-1 Therapy in Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 11, 2016
Last Updated: 09/26/2026